WESTPORT, Conn., June 12, 2014 /PRNewswire/ -- HemCon Medical
Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar
Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer
and marketer of advanced medical products, announced today that
Authors Dr. E.C.T.H. Tan and Dr.
J. Peters have published in the
Dutch Journal of TraumaSurgery encouraging results of a
study conducted between 2009 and 2013 using HemCon's hemostatic
chitosan-coated dressing ChitoGauze® on pre-hospital
bleeding patients by one of the four Dutch Helicopter-Mobile
Medical Teams; the Lifeliner3 of the Radboud University Medical
Center, Nijmegen the Netherlands.
Photo - http://photos.prnewswire.com/prnh/20140611/117207
Photo - http://photos.prnewswire.com/prnh/20140611/117184
During the study all injured trauma patients with massive
bleeding were successfully treated with HemCon ChitoGauze. Seventy
five percent (75%) of all bleeding could be stopped with
application of ChitoGauze, while in twenty five percent (25%) of
patients ChitoGauze helped to control the severity of bleeding. No
side effects were noted in the available follow up of 85.7% of all
study subjects. The conclusion of this study is that all degrees
(arterial, venous or combination of arterial and venous) of
bleeding could be stopped with the HemCon dressing and this offers
emergency medical personnel in both civilian and military settings
a versatile and highly effective hemostatic solution to help safely
stabilize patient for transport to definitive care.
"ChitoGauze has a proven track record of quickly controlling all
types of bleeding. HemCon's proprietary chitosan technology
provides a cost-effective hemostatic solution to treat routine to
most compromised patients, while also providing antibacterial
properties that may help reduce the risk of infection. HemCon's
ability to stop bleeding at all levels of the continuum of care
allows hospitals to add efficiencies to their normal practices as
well as greatly reducing everyday expenses, while improving patient
outcomes," said Michael Wax,
President and CEO, HemCon. "We are very gratified that this
important research conducted by Dr. Tan and Dr. Peters has been
published and is being presented to the trauma community."
Dr. Tan recently presented the study at the Scientific Program
of the European Congress of
Trauma and Emergency Surgery (ECTES)/World Trauma Congress in
Frankfurt, Germany. Results will
also be presented by Dr. Peters at the AIRMED World Congress in
Rome, Italy in June. "This
international exposure solidifies the recent decision of the U.S.
Military Committee on Combat Casualty Care (CoTCCC) to add
ChitoGauze to their guidelines for hemorrhage control in tactical
field and evacuation care." Added Mr. Wax.
For Instant Alerts and future press releases Text: TWSI
to 40691 "standard text mssg and data rates may
apply"
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops,
manufactures, and markets innovative technologies for hemostatic
devices for the control of bleeding resulting from trauma or
surgery. HemCon products are designed for use by military and
civilian first responders as well as medical professionals in
hospital and clinical settings where control of bleeding are of
critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of
the art manufacturing facility, the Company has additional
commercial operations in Ireland
and the Czech Republic. For more
information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and
wellness company that targets under-met consumer opportunities in
the OTC and professional marketplace. Its core strategy plans to
meet the growing demand for personalized, care solutions by
leveraging proprietary innovation and healthcare technology with
the rapid transformation of the healthcare marketplace to create
innovative, science based solutions and brands. TriStar recently
acquired HemCon Medical Technologies Inc., a developer,
manufacturer, and marketer of innovative technologies for
hemostatic devices for the control of bleeding resulting from
trauma or surgery. It also owns the Beauty de MamanTM brand of
women's health products. Additional information is available at
www.tstarwellness.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc.
contains forward-looking statements. Generally, you can identify
these statements because they use words like "anticipates,"
"believes," "expects," "future," "intends," "plans," and similar
terms. These statements reflect only our current expectations.
Although we do not make forward-looking statements unless we
believe we have a reasonable basis for doing so, we cannot
guarantee their accuracy and actual results may differ materially
from those we anticipated due to a number of uncertainties, many of
which are unforeseen, including, among others, the risks we face as
described our filings with the Securities and Exchange Commission.
You should not place undue reliance on these forward-looking
statements which apply only as of the date of this press release.
To the extent that such statements are not recitations of
historical fact, such statements constitute forward-looking
statements that, by definition, involve risks and uncertainties. In
any forward-looking statement where we express an expectation or
belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis,
but there can be no assurance that the statement of expectation of
belief will be accomplished.
Contact:
Simona Buergi
Tel: (503) 245-0459
simona.buergi@hemcon.com
Web site: http://www.tstarwellness.com
SOURCE TriStar Wellness Solutions